Cargando…

SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge – Denver, Colorado, and San Diego, California, January–April 2021

BACKGROUND: COVID-19 vaccination reduces SARS-CoV-2 infection and transmission. However, evidence is emerging on the degree of protection across variants and in high-transmission settings. To better understand the protection afforded by vaccination specifically in a high-transmission setting, we exa...

Descripción completa

Detalles Bibliográficos
Autores principales: McCormick, David W., Konkle, Stacey L., Magleby, Reed, Chakrabarti, Ayan K., Cherney, Blake, Lindell, Kristine, Namageyo-Funa, Apophia, Visser, Susanna, Soto, Raymond A., Donnelly, Marisa A.P., Stringer, Ginger, Austin, Brett, Beatty, Mark E., Stous, Sarah, Albanese, Bernadette A., Chu, Victoria T., Chuey, Meagan, Dietrich, Elizabeth A., Drobeniuc, Jan, Folster, Jennifer M., Killerby, Marie E., Lehman, Jennifer A., McDonald, Eric C., Ruffin, Jasmine, Schwartz, Noah G., Sheldon, Sarah W., Sleweon, Sadia, Thornburg, Natalie J., Hughes, Laura J., Petway, Marla, Tong, Suxiang, Whaley, Melissa J., Kirking, Hannah L., Tate, Jacqueline E., Hsu, Christopher H., Matanock, Almea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250903/
https://www.ncbi.nlm.nih.gov/pubmed/35803846
http://dx.doi.org/10.1016/j.vaccine.2022.06.066
Descripción
Sumario:BACKGROUND: COVID-19 vaccination reduces SARS-CoV-2 infection and transmission. However, evidence is emerging on the degree of protection across variants and in high-transmission settings. To better understand the protection afforded by vaccination specifically in a high-transmission setting, we examined household transmission of SARS-CoV-2 during a period of high community incidence with predominant SARS-CoV-2 B.1.1.7 (Alpha) variant, among vaccinated and unvaccinated contacts. METHODS: We conducted a household transmission investigation in San Diego County, California, and Denver, Colorado, during January-April 2021. Households were enrolled if they had at least one person with documented SARS-CoV-2 infection. We collected nasopharyngeal swabs, blood, demographic information, and vaccination history from all consenting household members. We compared infection risks (IRs), RT-PCR cycle threshold values, SARS-CoV-2 culture results, and antibody statuses among vaccinated and unvaccinated household contacts. RESULTS: We enrolled 493 individuals from 138 households. The SARS-CoV-2 variant was identified from 121/138 households (88%). The most common variants were Alpha (75/121, 62%) and Epsilon (19/121, 16%). There were no households with discordant lineages among household members. One fully vaccinated secondary case was symptomatic (13%); the other 5 were asymptomatic (87%). Among unvaccinated secondary cases, 105/108 (97%) were symptomatic. Among 127 households with a single primary case, the IR for household contacts was 45% (146/322; 95% Confidence Interval [CI] 40–51%). The observed IR was higher in unvaccinated (130/257, 49%, 95% CI 45–57%) than fully vaccinated contacts (6/26, 23%, 95% CI 11–42%). A lower proportion of households with a fully vaccinated primary case had secondary cases (1/5, 20%) than households with an unvaccinated primary case (66/108, 62%). CONCLUSIONS: Although SARS-CoV-2 infections in vaccinated household contacts were reported in this high transmission setting, full vaccination protected against SARS-CoV-2 infection. These findings further support the protective effect of COVID-19 vaccination and highlight the need for ongoing vaccination among eligible persons.